Polygenic risk score and biochemical/environmental variables predict a low-risk profile of age-related macular degeneration in Sardinia

[1]  G. Abecasis,et al.  Author Correction: Complex genetic signatures in immune cells underlie autoimmunity and inform therapy , 2020, Nature Genetics.

[2]  Nicola B Quinn,et al.  Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease , 2019, bioRxiv.

[3]  J. P. Andrade,et al.  Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review , 2017, Oxidative medicine and cellular longevity.

[4]  M. DeAngelis,et al.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors , 2016, Eye and Vision.

[5]  Yara T. E. Lechanteur,et al.  Nature Genetics Advance Online Publication , 2022 .

[6]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2016 .

[7]  Alan M. Kwong,et al.  Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers , 2015, Nature Genetics.

[8]  M. Dore,et al.  Male longevity in Sardinia, a review of historical sources supporting a causal link with dietary factors , 2014, European Journal of Clinical Nutrition.

[9]  Sina Farsiu,et al.  Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. , 2013, Investigative ophthalmology & visual science.

[10]  T. Peto,et al.  The Prevalence of Age-Related Macular Degeneration in Italy (PAMDI) Study: Report 1 , 2011, Ophthalmic epidemiology.

[11]  K Bailey Freund,et al.  Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.

[12]  A. Harris,et al.  Age-related macular degeneration and the aging eye , 2008, Clinical interventions in aging.

[13]  Don H. Anderson,et al.  Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.

[14]  C. Franceschi,et al.  Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity , 2007, European Journal of Clinical Nutrition.

[15]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[16]  G. Abecasis,et al.  Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians , 2006, PLoS genetics.

[17]  M. Whalen,et al.  Low Frequency of the CFH Polymorphism T1277C Contributes to a Low Prevalence of AMD in a Sardinian Genetic Isolate , 2006 .

[18]  Matthew D. Davis,et al.  The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration , 2015 .

[19]  Johanna M Seddon,et al.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.

[20]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[21]  Marco A Zarbin,et al.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[22]  R. Klein,et al.  The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. , 2003, Ophthalmology.

[23]  A. Hofman,et al.  Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.

[24]  J. J. Wang,et al.  Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. , 1998, Archives of ophthalmology.

[25]  Johannes R. Vingerling,et al.  The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.

[26]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[27]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[28]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[29]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[30]  R. Klein,et al.  Risk Factors Associated with Age-Related Macular Degeneration: A Case-control Study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study , 2000 .

[31]  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. , 2000, Ophthalmology.

[32]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[33]  A. Clauss.  [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.